Apollo Medical Holdings, Inc. (AMEH) - P/E multiplikatori

Apollo Medical Holdings Inc. - AMEH emitenti grafik logotipi

Apollo Medical Holdings (AMEH) rahbariyati qat'iy moliyaviy intizomni saqlamoqda va klinikalarning raqamli transformatsiyasi orqali barqaror foydani ta'minlamoqda. Biznes sug'urta kompaniyalari bilan uzoq muddatli kelishuvlarga tayanib, terapiya xarajatlarini optimallashtirishni monetizatsiya qiladi. Joriy ko'rsatkich 29.30 hisoblanadi. ASTH (avvalgi AMEH) qimmatli qog'ozlarining narx dinamikasi shifokorlar sonini ko'paytirmasdan, davolashni muvofiqlashtirish uchun bulutli dasturiy ta'minotning kengayish salohiyatini namoyish etadi.

AMEH (Apollo Medical Holdings Inc.) Narxning foydaga nisbati tarixi 04.07.2022dan 15.11.2026gacha

Apollo Medical Holdings kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:AMEH (ApolloMed)
ApolloMed brendining mahsuloti

Apollo Medical Holdings (AMEH) ning qiymatga asoslangan parvarish modeli sug'urta to'lovlarini kamaytirish orqali davolash samaradorligini monetizatsiya qilish imkonini beradi. P/E koeffitsiyenti aksiyalarning joriy bozor qiymatini yillik sof foyda bilan solishtirib, bir dollar foydaning tannarxini belgilaydi. Apollo Medical Holdings (AMEH) ning P/E dinamikasini tahlil qilish orqali investor biznesning operatsion rentabelligiga nisbatan qanchalik hadda qimmat baholanganligini aniqlashi mumkin. Pasayish tendentsiyasi chizig'i aktivlarning past baholanganligini yoki o'sish sur'atlarining sekinlashishini anglatishi mumkin. Yakuniy tendentsiya emitentning kelgusidagi pul oqimlari bo'yicha bozor konsensusini aks ettiradi.

Raqobatdosh kompaniyalar

Narx-foyda multiplikatori VEEV (Veeva Systems Inc)|P/E multiplikatori DOCS|HQY - Kapitalizatsiyaning foydaga nisbati|Waystar Health - Narx-foyda koeffitsiyenti|corvel.com (CRVL) - Kapitalizatsiyaning foydaga nisbati|Privia Health Group, Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati HURN (Huron Consulting Group Inc.)|CERT (Certara) - Narx-foyda koeffitsiyenti|OMCL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati GoodRx Holdings, Inc.|Kapitalizatsiyaning foydaga nisbati Schrodinger, Inc. SDGR|P/E multiplikatori PHR|OMDA (Omada Health) - Kompaniya qiymatining sof foydaga nisbati|Evolent - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati HealthStream, Inc. (HSTM)|Definitive Healthcare Corp - P/E multiplikatori|CCSI - P/E multiplikatori|AGL: P/E multiplikatori|ABSI - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti SY|Kapitalizatsiyaning foydaga nisbati National Research Corp. NRC|Narxning foydaga nisbati Spok (SPOK)|OPRX (OptimizeRx Corporation) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CPSI TBRG|SLP (Simulations Plus Inc) - Kapitalizatsiyaning sof foydaga nisbati|Sophia Genetics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Health Catalyst Inc|CCLD (CareCloud, Inc.) - Narx-foyda koeffitsiyenti|RSSS: Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati DLH Corp|Kapitalizatsiyaning foydaga nisbati onemednet.com ONMD|Narxning foydaga nisbati Scienture Holdings Inc (SCNX)|Healthcare Triangle Corp - Narx-foyda multiplikatori|Narxning foydaga nisbati iSpecimen Inc ISPC|Biznesning o‘zini qoplash muddati Bullfrog AI Holdings (BFRG)|WORX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati MSP Recovery Inc. MSPR|ICCT: P/E multiplikatori|Narx-foyda koeffitsiyenti TRxADE|Narx-foyda koeffitsiyenti ORGS|P/E multiplikatori R1 RCM|Narx-foyda koeffitsiyenti SHCR (Sharecare)|Narxning foydaga nisbati STRM (Streamline Health Solutions Inc.)|P/E multiplikatori SYRA (Syra Health, Corp.)|MODN: Narx-foyda multiplikatori|nextgen.com - P/E multiplikatori